The cell surface antigen, epithelial glycoprotein, defined by the monoclonal antibody HEA 125, is expressed on virtually all epithelial cell membranes but not on mesodermal or neural cell membranes. The cDNA encoding epithelial glycoprotein was isolated by HEA 125 antibody enrichment ofcolon tumor cDNA expressed transiently in COS cells. The sequence of the epithelial glycoprotein antigen is identical to the cell membrane protein recognized by the monoclonal antibody KS 1/4 and is homologous to the tumor-assoiated antigen GA733.
1/4 and is homologous to the tumor-assoiated antigen GA733.
These proteins share sequence homology to nidogen, an extracellular matrix component that appears to participate in cellmatrix adhesion. These proteins also share a homologous domain found in the Bi chain of laminin, a matrix adhesion protein, and placental protein 12, an insuidn-like growth factor I binding protein secreted during pregnancy that has been implicated in regulation of fetal growth. This common domain is also repeated multiple times within the thyroglobulin precursor. These fin gs suggest epithelial glycoprotein is a cell surface molecule involved in cell-cell or cell-matrix interaction.
The normal epithelial cell surface contains a complex and functionally diverse array of membrane glycoproteins that mediate many different cellular recognition functions. These include a wide variety of receptors and transporters as well as glycoproteins that mediate cell-cell or cell-matrix interactions (1, 2) . Often these glycoproteins have been recognized through characterization of surface antigens on tumor cells by the development of monoclonal antibodies after immunization of mice with cells or cell-membrane preparations (3) (4) (5) (6) . Characterization of antigens first identified through their association with transformation has led to the recognition of functionally important constituents of the normal epithelial cell surface. Indeed, most tumor-associated cell surface antigens identified in this manner have proven to be present on nontransformed cells (3) .
Although the functions of most tumor cell-associated surface determinants identified in this manner remain unknown, some of those membrane glycoprotein antigens may participate in cell-cell or cell-matrix interactions (7, 8) . Thus the carcinoma embryonic antigen (CEA) was identified after immunization with tumor tissue (37) . However, subsequent studies demonstrated that CEA is not a tumor-specific antigen (38) . Although neoplastic transformation results in quantitative and qualitative abnormalities in CEA expression, it is also expressed in normal epithelial cells (7) . The homogeneous cell surface expression of tumor cells resembles the pattern of surface expression seen in fetal epithelia (7) . Most interestingly, studies have shown that CEA confers homophilic binding on CEA-expressing cells (7) . Among surface antigens defined by monoclonal antibodies (mAbs), the epithelial glycoprotein antigen (EGP) recognized by mAb HEA 125 may prove especially interesting (9, 10 (9) .
Although EGP is expressed in a polarized manner at the basolateral surface of normal epithelial cells, EGP in staining was more homogeneous on the membranes of tumor cells (9) . Therefore, the changes in EGP expression seen with transformation resemble those of CEA, which has been shown to contribute to cell-cell adhesion of some colon tumor cells (7). These observations suggest that EGP may also play a role in fundamental cell-cell or cell-matrix interactions of epithelial cells.
To further elucidate the function of EGP, the structure of EGP* was determined through molecular cloning using mAb HEA 125 in the "cell-panning" technique (13, 14) . The EGP cDNA encodes a transmembrane protein that is identical to the antigen recognized by the mAb KS 1/4 (11) and highly homologous to the GA 733-1 antigen (12 Isolation of EGP cDNA Clones. The cDNAs encoding the EGP surface antigen were isolated using the antibodyenrichment method of Seed and Aruffo (13, 14) . A cDNA Abbreviations: EGP, epithelial glycoprotein antigen; mAb, monoclonal antibody; CEA, carcinoma embryonic antigen; IGF-I, insulinlike growth factor I. *The sequence reported in this paper has been deposited in the GenBank data base (accession no. M32306).
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Proc. Natl. Acad. Sci. USA 87 (1990) library, prepared from the HT-29 (human colon carcinoma derived) cell line, was ligated into the cdm8 expression vector and then transfected into COS cells by the DEAE-dextran method. Transfected COS cells were resuspended 48 hr later, then incubated with mAb HEA 125 (1 tug/ml), and replated onto dishes coated with affinity-purified goat anti-mouse IgG antibody. A Hirt extract of episomal DNA prepared from adherent cells was used to transform competent Escherichia coli. The resulting bacterial colonies were pooled, amplified, and subjected to spheroblast fusion with COS cells. Transfected COS cells expressing EGP were subjected to a second round of selection by "antibody panning." After a third round of panning, DNA was isolated from bacterial colonies by the alkaline miniprep method and transfected into COS cell cultures. The presence of EGP was detected by indirect immunofluorescence (15 , and electrophoresed on a 10% polyacrylamide gel containing SDS. The gel was fixed, soaked in EN3HANCE (New England Nuclear), dried, and exposed to Kodak x-ray film at -70°C. 14C-Methylated molecular weight markers (Amersham) calibrated the molecular weight of labeled proteins.
RNA Blot Hybridization. Total RNA was extracted from cells and tissues by using the method of Cathala et al. (16) , and poly(A)+ RNA was isolated by oligo(dT)-cellulose chromatography (17) and then subjected to Northern blot analysis after electrophoresis through a 1% denaturing agarose gel (18) . RNA blots were hybridized with a 32P-labeled EGP cDNA insert labeled by nick-translation (19) . After hybridization, filters were washed at 65°C in O.lx SSC/0.1% SDS (lx SSC = 0.15 M NaCl/0.015 M sodium citrate, pH 7.0) and subjected to autoradiography at -70°C.
cDNA Sequence Analyses. The EGP cDNA inserts were subcloned into M13mpl8 (20) and the cDNA sequence was determined by the dideoxynucleotide method (21) using 35S-labeled dATP and T7 DNA polymerase (Sequenase; United States Biochemical). Some sequence data were obtained by specific priming of M13 clones with synthetic oligonucleotides prepared by an automatic DNA synthesizer (Applied Biosystems). The sequences of clone 1 and 3 were determined in both strands; clone 5 was sequenced in only one direction.
RESULTS AND DISCUSSION Isolation of a cDNA Encoding EGP. A cDNA library prepared from the HT-29 cell line was ligated into the cdm8 vector and transfected into COS cells by the DEAE-dextran method (13, 14) . The transfected cells were pooled 48 hr after transfection, incubated with mAb HEA 125, and then panned on dishes coated with goat anti-mouse affinity-purified antibody. After three washes, the adherent cells were lysed; (Fig. 2) . A 1.6-kb EGP transcript was found in HT-29, SW948, and SW837, colon carcinoma-derived cell lines. Approximately equal levels of the 1.6-kb EGP mRNA were seen in undifferentiated (sucrase-minus) and differentiated (sucrasepositive) CaCo2 cells (Fig. 2) . EGP mRNA levels in normal colon mucosa were equivalent to those seen in colon tumor cells consistent with the previous conclusion that EGP is expressed by normal colonic epithelial cells and is not a tumor-specific antigen. EGP mRNA was not expressed in the hemopoietic cell line HPB-ALL or the neural cell line SYSY. These results are consistent with immunohistochemical data on the expression of EGP protein exclusively in epithelial cells (9, 10 protein sequence (Fig. 3) . Clones EGP3 and -5 cDNA differed from EGP1 by having 160 base pairs of 5' noncoding sequence compared to 16 base pairs in EGP1. All three clones had identical 3' sequences terminating in an AATAAA polyadenylylation signal followed 15 nucleotides downstream by a poly(A) sequence. The EGP cDNA clones contained a 942-nucleotide open reading frame after the initiator AUG codon. This AUG codon is preceded by a CAGGC sequence, which conforms to the Kozak consensus for eukaryotic translational initiation (22) .
The cDNA encodes a protein sequence of 314 amino acids that resembles a transmembrane protein. The first 21 amino acids comprise a characteristic hydrophobic signal sequence. By following the -3 -1 von Heijne rule (23), the predicted site of signal cleavage is after the Thr-Phe-Ala sequence, implying that an alanine is the N-terminal residue of EGP expressed on the cell membrane. The extracellular domain is comprised of the N-terminal 80o of mature EGP, which is anchored to the membrane by a hydrophobic 21-amino acid sequence followed by a short charged sequence of 4 basic amino acids lying in the cytoplasm that acts as a stop-transfer sequence. The predicted intracytoplasmic domain of EGP is very short, comprising only the C-terminal 26 amino acids. The predicted extracellular domain of the protein contains three potential N-linked glycosylation sites (Asn-XaaSer/Thr). If these sites are glycosylated posttranslationally, the predicted molecular mass of the native protein encoded by the EGP cDNA would be approximately 40 kDa assuming (12) proteins. The entire sequences of EGP residues (1-314) and GA733 residues (1-323) were compared using the ALIGN program with the mutation data matrix (250-point-accepted mutations) and a gap penalty of 6. The alignment score was 39.85 standard deviations; a score greater than 8 standard deviations indicates highly significant homology. Identical amino acid residues are shown below. The single-letter amino acid code is used. Fig. 4 . Identical amino acid residues are shown below. The single-letter amino acid code is used.
The extracellular domain has two tandem sequences containing repeated cysteine residues (repeats 1 and 2, Fig. 3 (11) . EGP is also highly homologous to another tumor antigen recognized by the mAb GA 733 (12) (Fig. 4) . Although sequence identities extend through the entire length of the protein, highest sequence conservation occurs between residues in the second cysteine repeat (EGP amino acids 91-130) and in the hydrophobic transmembrane domain. Furthermore, EGP shows sequence similarity to nidogen (27) , a cell matrix protein, and placental protein 12, an IGF-I-binding protein secreted by the placenta (28, 29) . EGP shares with these proteins a similar pattern of cysteine repeats (Fig. 5a ) and a homologous sequence of 50 amino acids that is also repeated at least five times in the thyroglobulin precursor (ref. 30 and Fig. 5b ). This common 50-amino acid sequence is also similar to the sequence between residues 1111 and 1159 in the laminin B1 chainanother matrix adhesion protein (ref. 31 and Fig. Sb) .
The homology between EGP and nidogen extends beyond the thyroglobulin-like domain to include the adjacent upstream amino acids (Fig. Sc) . In nidogen, the EGP-homologous sequence is part of a much larger multifunctional 1217-amino acid protein that comprises three domains: an N-terminal 85-kDa globular domain, a central 27-kDa rod-like domain, and a 38-kDa globular C-terminal domain. The C-terminal domain binds laminin and collagen, anchoring nidogen in the basement membrane. The central rod-like domain contains five epidermal growth factor-like cysteine repeats and a single RGD (Arg-Gly-Asp) sequence, which mediates cell adhesion (27) . Although the central rod-like domain of nidogen contains the EGP-like sequence, the RGD sequence mediating nidogen cell adhesion lies upstream of the EGP-like sequence and this common cell adhesion sequence is not found in EGP.
EGP is also homologous to placental protein 12, which is secreted by the endometrium into the amniotic fluid during the first trimester-of pregnancy (28, 32, 33) . Interestingly, many types of tumors express high levels of placental protein 12 (34, 35) . While the biological actions of placental protein 12 are unknown, the IGF-I binding capability and its secretion into amniotic fluid suggests that placental protein 12 may regulate fetal growth (36) .
Although the sequence homology of EGP to nidogen and placental protein 12 
